Latest1 information on COVID-19
©2022 Stanford Medicine
Not Recruiting
Trial ID: NCT01492569
Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric)
Inclusion Criteria:
- Patient with a planned admission for at least 24 hours for highly emetogenic or
moderately emetogenic chemotherapy at Lucile Packard Children's Hospital or Packard El
Camino.
- Planned to undergo at least 2 more cycles of chemotherapy.
- Can include but not limited to: children with high risk ALL, AML, Ewing's Sarcoma,
Osteosarcoma
- History of vomiting with prior cycles of chemotherapy (2 episodes of emesis at
minimum) despite use of conventional antiemetic medications.
- Age 8-21.
- Parent must be able to understand and willing to sign written informed consent
document.
Exclusion Criteria:
- Prior knowledge of acupuncture or experience with acupuncture or acupressure.
- There will be no restrictions regarding use of other Investigational Agents.
- Comorbid Diseases:
- Diagnosis of any cardiac condition (cardiomyopathy, arrhythmia, pacemaker
placement).
- Any diagnosis requiring pediatric intensive care unit admission.
- Patients with brain tumor, brain metastasis (these patients often require
radiation and surgery in addition to chemotherapy which may confound the results)
- Concomitant radiation therapy during current chemotherapy cycle.
- Developmental delay patients with allergy to tape or leads will be excluded from
the study.
- Pregnant patients will be excluded from the study.
- Cancer survivors will not be excluded from the study as long as they are undergoing
chemotherapy treatment for their current cancer therapy.
- HIV-positive patients will not be excluded.
procedure: electroacupuncture therapy
other: questionnaire administration
procedure: electroacupuncture therapy
Not Recruiting
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Brenda Golianu
650-723-5728